Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Merck
Johnson and Johnson
Baxter
Dow

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TOFACITINIB CITRATE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for tofacitinib citrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02197455 Tofacitnib for the Treatment of Alopecia Areata and Variants Completed Yale University Phase 2 2014-07-01 The purpose of this study is to investigate the ability of tofacitinib citrate, a Janus kinase inhibitor, to generate hair regrowth in patients with moderate to severe alopecia areata and its variants.
NCT02312882 Tofacitinib for the Treatment of Alopecia Areata and Its Variants Active, not recruiting Stanford University N/A 2014-12-01 The purpose of this study is to investigate the ability of tofacitinib citrate, a Janus kinase inhibitor, to generate hair regrowth in patients with moderate to severe alopecia areata and its variants.
NCT03002649 Study of Tofacitinib in Refractory Dermatomyositis Recruiting Pfizer Phase 1 2017-01-01 The purpose of this study is to obtain preliminary data regarding the safety and efficacy of Janus kinase (JAK) inhibitor, tofacitinib, in adults with active, treatment-refractory dermatomyositis.
NCT03002649 Study of Tofacitinib in Refractory Dermatomyositis Recruiting Johns Hopkins University Phase 1 2017-01-01 The purpose of this study is to obtain preliminary data regarding the safety and efficacy of Janus kinase (JAK) inhibitor, tofacitinib, in adults with active, treatment-refractory dermatomyositis.
NCT04114461 Study to Evaluate HL-TOF Tab. 5 mg Compared With XelJanz Tab. in Healthy Volunteers Recruiting Hanlim Pharm. Co., Ltd. Phase 1 2019-11-01 To evaluate the safety and pharmacokinetics of HL-TOF tab. 5 mg compared with those of XelJanz tab. in healthy volunteers
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for tofacitinib citrate

Condition Name

Condition Name for tofacitinib citrate
Intervention Trials
Alopecia Universalis 1
Alopecia Totalis (AT) 1
Alopecia Totalis 1
Alopecia Areata (AA) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for tofacitinib citrate
Intervention Trials
Alopecia Areata 2
Alopecia 2
Dermatomyositis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for tofacitinib citrate

Trials by Country

Trials by Country for tofacitinib citrate
Location Trials
United States 3
Korea, Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for tofacitinib citrate
Location Trials
Maryland 1
California 1
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for tofacitinib citrate

Clinical Trial Phase

Clinical Trial Phase for tofacitinib citrate
Clinical Trial Phase Trials
Phase 2 1
Phase 1 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for tofacitinib citrate
Clinical Trial Phase Trials
Recruiting 2
Active, not recruiting 1
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for tofacitinib citrate

Sponsor Name

Sponsor Name for tofacitinib citrate
Sponsor Trials
Hanlim Pharm. Co., Ltd. 1
Johns Hopkins University 1
Pfizer 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for tofacitinib citrate
Sponsor Trials
Other 3
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKinsey
Harvard Business School
Johnson and Johnson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.